Regular Article
Ontogeny of Cardiacβ-Adrenoceptor Desensitization Mechanisms: Agonist Treatment Enhances Receptor/G-Protein Transduction Rather than Eliciting Uncoupling

https://doi.org/10.1006/jmcc.1998.0875Get rights and content

Abstract

In the fetus and neonate,β-adrenoceptor stimulation fails to produce physiological desensitization. The current study explores the mechanisms underlying the response pattern in neonatal rats. Homologous cardiacβ-adrenergic desensitization caused by isoproterenol treatmentin vivowas demonstrable in adult rats by the immediate (2 h) and specific loss of the ability of isoproterenol, but not glucagon, to stimulate adenylyl cyclasein vitro. Homologous desensitization was absent when the same treatment was given to neonates. By 12 h post-treatment, the adults showed heterologous desensitization (loss of the response to glucagon), an effect which was once again absent in the immature rats. The absence of desensitization in neonates did not reflect a deficiency in the activity or subcellular distribution ofβARK1, the enzyme that initiates the phosphorylation and consequent desensitization ofβ-adrenoceptors. On the other hand, neonates showed relatively poor receptor-Gstransduction as assessed by the GTP-induced shift in receptor ligand binding. Repeated isoproterenol treatment of adult rats led to uncoupling of receptor-G-protein transduction but the same treatment in neonatesenhancedtransduction. Furthermore, neonatal sympathectomy with 6-OHDA interfered with the ontogenetic rise inβ-adrenoceptor-Gsinteractions. These results indicate that the maintenance of agonist responses in the face of neonatal adrenergic stimulation does not reflect simply an absence of the ability to elicit homologous or heterologous desensitization but rather represents an active regulatory mechanism in which neural input exerts a positive trophic role at the level of G-protein function.

References (0)

Cited by (48)

  • Cardiac Physiology and Pharmacology

    2019, A Practice of Anesthesia for Infants and Children
  • Cardiac Physiology and Pharmacology

    2018, A Practice of Anesthesia for Infants and Children
  • Pharmacology of the Cardiovascular System

    2011, Pediatric Critical Care: Expert Consult Premium Edition
  • Pharmacology of the Cardiovascular System

    2011, Pediatric Critical Care
  • Organophosphate exposure during a critical developmental stage reprograms adenylyl cyclase signaling in PC12 cells

    2010, Brain Research
    Citation Excerpt :

    Our AC assessments focused on measures that evaluate pathway function at sequential steps: basal enzymatic activity, the response to global stimulation of G-proteins by fluoride, and the responses to two direct AC stimulants, forskolin and Mn2+. Because the two stimulants act at different epitopes on the AC molecule, the preferential effects for one versus the other define shifts in the expression and catalytic activities of different AC isoforms (Auman et al., 2000; Zeiders et al., 1997, 1999a). We then compared the effects on AC signaling to those on cell growth, focusing on measures of cell number and neurite formation.

  • Neonatal parathion exposure and interactions with a high-fat diet in adulthood: Adenylyl cyclase-mediated cell signaling in heart, liver and cerebellum

    2010, Brain Research Bulletin
    Citation Excerpt :

    In addition to assessing basal AC activity, we evaluated responses to 100 μM isoproterenol, 3 μM glucagon, 10 mM NaF and 100 μM forskolin. These concentrations produce maximal responses to each stimulant as assessed in earlier studies [3,31,32]. To evaluate βAR binding, aliquots of the same membrane preparation were incubated with 67 pM [125I]-iodopindolol in 145 mM NaCl, 2 mM MgCl2, 1 mM sodium ascorbate, 20 mM Tris (pH 7.5), for 20 min at room temperature; samples were evaluated with and without 100 μM isoproterenol to displace specific binding.

View all citing articles on Scopus
f1

Please address correspondence to: Dr T. A. Slotkin, Box 3813, Department of Pharmacology & Cancer Biology, Duke University Medical Center, Durham, NC 27710, USA.

View full text